AI assistant
PYC THERAPEUTICS LIMITED — Director's Dealing 2010
Mar 16, 2010
65640_rns_2010-03-16_0542e6d4-3a3d-4c0e-921f-83fb51eff3d5.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y
Change of Director’s Interest Notice
Name of entity PHYLOGICA LIMITED ABN 48 098 391 961
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | PAUL MICHAEL WATT |
|---|---|
| Date of last notice | 19 February 2010 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | INDIRECT | ||
|---|---|---|---|
| Nature of indirect interest | PAUL MICHAEL WATT AND | MARIA | |
| (including registered holder) | DEL PILAR ENRIQUEZ-WATT | ||
| Note: Provide details of the circumstances giving rise to the relevantinterest. | ATF THE BRAINCHILD SUPER FUND | ||
| INTEREST:TRUSTEE | & | FUND | |
| BENEFICIARY | |||
| Date of change | 15 MARCH 2010 | ||
| No. of securities held prior to change | DIRECT | ||
| 4,044,123 ORDINARY SHARES | |||
| INDIRECT | |||
| 822,908 ORDINARY SHARES | |||
| 20,000 CONVERTIBLE NOTES | |||
| Class | ORDINARY SHARES | ||
| Number acquired | 100,000 | ||
| Number disposed | NIL | ||
| Value/Consideration | $9,628.46 | ||
| Note: If consideration is non-cash, provide details and estimated | |||
| valuation | |||
| No. of securities held after change | DIRECT | ||
| 4,044,123 ORDINARY SHARES | |||
| INDIRECT | |||
| 922,908 ORDINARY SHARES | |||
| 20,000 CONVERTIBLE NOTES |
1
Nature of change ON MARKET PURCHASE OF SHARES Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | Detail of contract | Detail of contract | N/A | N/A | N/A | N/A | N/A |
|---|---|---|---|---|---|---|---|
| Nature of interest | |||||||
| Name of registered holder(if issued securities) | |||||||
| Date of change | |||||||
| No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changed | |||||||
| Interest acquired | |||||||
| Interest disposed | |||||||
| alue/ConsideraNote: If consideration is nn estimated valuation | tionon-cash, provide details and | ||||||
| tt ft h | |||||||
| neres aer c | nge | ||||||
2
- See chapter 19 for defined terms.
Appendix 3Y Page
11/3/2002